作为前列腺癌的抗肿瘤药物的庚烯醇吡喃酮和吗啉酮。
Haloenol pyranones and morpholinones as antineoplastic agents of prostate cancer.
机构信息
Department of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA 30602-2352, USA.
出版信息
Bioorg Med Chem Lett. 2012 Jul 15;22(14):4854-8. doi: 10.1016/j.bmcl.2012.05.038. Epub 2012 May 17.
Abstract
Haloenol pyran-2-ones and morpholin-2-ones were synthesized and evaluated as inhibitors of cell growth in two different prostate human cancer cell lines (PC-3 and LNCaP). Analogs derived from L- and D-phenylglycine were found to be the most effective antagonists of LNCaP and PC-3 cell growth. Additional studies reveal that the inhibitors induced G2/M arrest and the (S)-enantiomer of the phenylglycine-based derivatives was a more potent inhibitor of cytosolic iPLA(2)β.
摘要
合成了偕-烯醇吡喃-2-酮和吗啉-2-酮，并将其作为两种不同的前列腺人癌细胞系（PC-3 和 LNCaP）中细胞生长的抑制剂进行了评估。从 L-和 D-苯甘氨酸衍生出的类似物被发现是 LNCaP 和 PC-3 细胞生长的最有效拮抗剂。进一步的研究表明，这些抑制剂诱导 G2/M 期阻滞，并且基于苯甘氨酸的衍生物的（S）对映体是细胞溶质 iPLA(2)β 的更有效的抑制剂。
相似文献
1
Haloenol pyranones and morpholinones as antineoplastic agents of prostate cancer.
Bioorg Med Chem Lett. 2012 Jul 15;22(14):4854-8. doi: 10.1016/j.bmcl.2012.05.038. Epub 2012 May 17.
2
Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase.
J Med Chem. 2007 Apr 19;50(8):1958-72. doi: 10.1021/jm061121y. Epub 2007 Mar 20.
3
New Approaches for the Synthesis of Fused Thiophene, Pyrazole, Pyran and Pyridine Derivatives with Anti-Proliferative Together with c-Met Kinase and Prostate Cancer Cell Inhibitions.
Anticancer Agents Med Chem. 2021;21(13):1751-1766. doi: 10.2174/1871520620999201110191056.
4
20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Anticancer Res. 1999 May-Jun;19(3A):1689-97.
5
Phthalocyanine derivatives possessing 2-(morpholin-4-yl)ethoxy groups as potential agents for photodynamic therapy.
J Med Chem. 2015 Mar 12;58(5):2240-55. doi: 10.1021/acs.jmedchem.5b00052. Epub 2015 Mar 3.
6
Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin.
J Mol Endocrinol. 1997 Aug;19(1):15-27. doi: 10.1677/jme.0.0190015.
7
4-aryl/heteroaryl-4H-fused Pyrans as Anti-proliferative Agents: Design, Synthesis and Biological Evaluation.
Anticancer Agents Med Chem. 2018;18(1):57-73. doi: 10.2174/1871520617666170918143911.
8
Synthetic cannabinoid quinones: preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity.
Eur J Med Chem. 2013;70:111-9. doi: 10.1016/j.ejmech.2013.09.043. Epub 2013 Oct 2.
9
Discovery and SAR of methylated tetrahydropyranyl derivatives as inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT).
J Med Chem. 2011 Jul 28;54(14):5031-47. doi: 10.1021/jm200249a. Epub 2011 Jun 28.
10
Multi-Component Reactions of Cyclohexan-1,3-dione: Synthesis of Fused Pyran, Pyridine, Thiophene and Pyrazole Derivatives with c-Met, Anti-Proliferative Activities.
Anticancer Agents Med Chem. 2021;21(17):2443-2463. doi: 10.2174/1871520621666210112115128.
引用本文的文献
1
Towards lipidomics of low-abundant species for exploring tumor heterogeneity guided by high-resolution mass spectrometry imaging.
Int J Mol Sci. 2013 Dec 17;14(12):24560-80. doi: 10.3390/ijms141224560.
本文引用的文献
1
Chelation-controlled ester-derived titanium enolate aldol reaction: diastereoselective -aldols with mono- and bidentate aldehydes.
Tetrahedron Lett. 2002 Aug 5;43(32):5621-5624. doi: 10.1016/S0040-4039(02)01113-9. Epub 2002 Jul 17.
2
Potent and selective inhibitors of glutathione S-transferase omega 1 that impair cancer drug resistance.
J Am Chem Soc. 2011 Oct 19;133(41):16605-16. doi: 10.1021/ja2066972. Epub 2011 Sep 27.
3
Inhibition of calcium-independent phospholipase A2 activates p38 MAPK signaling pathways during cytostasis in prostate cancer cells.
Biochem Pharmacol. 2010 Jun 15;79(12):1727-35. doi: 10.1016/j.bcp.2010.02.005. Epub 2010 Feb 18.
4
Role of Ca2+-independent phospholipase A2 in cell growth and signaling.
Biochem Pharmacol. 2008 Oct 30;76(9):1059-67. doi: 10.1016/j.bcp.2008.07.044. Epub 2008 Aug 15.
5
Inhibition of Ca2+-independent phospholipase A2 decreases prostate cancer cell growth by p53-dependent and independent mechanisms.
J Pharmacol Exp Ther. 2008 Jul;326(1):59-68. doi: 10.1124/jpet.108.138958. Epub 2008 Apr 25.
6
Inhibition of calcium-independent phospholipase A2 suppresses proliferation and tumorigenicity of ovarian carcinoma cells.
Biochem J. 2007 Sep 15;406(3):427-36. doi: 10.1042/BJ20070631.
7
Phospholipase A2 as targets for anti-cancer drugs.
Biochem Pharmacol. 2007 Oct 1;74(7):949-59. doi: 10.1016/j.bcp.2007.04.021. Epub 2007 Apr 27.
8
The phospholipase A2 superfamily and its group numbering system.
Biochim Biophys Acta. 2006 Nov;1761(11):1246-59. doi: 10.1016/j.bbalip.2006.07.011. Epub 2006 Aug 3.
9
Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders.
Pharmacol Rev. 2006 Sep;58(3):591-620. doi: 10.1124/pr.58.3.7.
10
Calcium-independent phospholipase A2 and apoptosis.
Biochim Biophys Acta. 2006 Nov;1761(11):1344-50. doi: 10.1016/j.bbalip.2006.07.013. Epub 2006 Aug 3.
Zotero 插件